birth weights (62,000 infants/year). 6 Hintz et al. 8 demonstrated that approximately 36% of extremely premature (< 25 weeks) infants develop Grade III or IV IVH. In a retrospective, multicenter cohort of preterm infants with IVH within the HCRN, our group has found that 40% of these patients required some treatment for hydrocephalus, of which 78% underwent permanent shunt insertions. 18 Hence, we can expect approximately 9000 new children per year in the US with hydrocephalus from prematurity alone.
The management of hydrocephalus in this population is complex. At the moment, however, there is little evidence to guide this management. The goal of this study was to examine the factors associated with surgical CSF diversion, thereby informing the development of algorithms for the treatment of preterm infants with IVH and hydrocephalus. The primary objective of this study was to determine the clinical and neuroimaging factors associated with 1) the implantation of temporizing devices and 2) the conversion of these temporizing devices to permanent CSF shunts among premature neonates with IVH. The secondary objective was to describe variations in practice patterns across 4 pediatric neurosurgical centers.
Methods

Study Design
This retrospective cohort study included infants treated at HCRN centers between January 1, 2000, and August 31, 2008. Each of the 4 centers consecutively enrolled the last 25-32 children who fit the inclusion and exclusion criteria. The study was developed and conducted through the HCRN, which, at the time of the study implementation, included 4 clinical centers representing 2 countries and a data coordinating center. All 5 centers obtained institutional review board approval at their respective locales, all with waiver of consent.
Patient Sample
Enrolled patients included preterm infants born at < 37 weeks of gestation, with birth weights of < 1500 g and Grade III or IV IVHs on neuroimaging who underwent implantation of a temporizing device or a permanent CSF shunt for IVH-related hydrocephalus at an HCRN center. Infants meeting these criteria who died within 1 month of birth were excluded.
Treatment Outcomes
Implanted temporizing devices included either ventricular reservoirs 12 or subgaleal shunts. 7 No external ventricular devices were used as temporizing measures in this study. Conversion to a permanent CSF shunt was our proxy for permanent hydrocephalus and was recorded only for those patients who had previously had an implanted temporizing device placed within 6 months. Endoscopic third ventriculostomy was not used in any patients in this study.
Clinical Characteristics
Clinical factors were evaluated via retrospective chart review. At least 20% of the abstracted chart data were collected in duplicate at each center to confirm and report abstraction accuracy. Gestational age, birth weight, sex, race or ethnicity, apnea and bradycardia episodes, and center of treatment were all recorded. The presence of splayed sutures and a bulging or full fontanel was documented if noted by either neurosurgery or neonatology physicians in the patient's chart. The OFCs and percentiles were recorded at birth, 32 weeks, 41 weeks, and before surgery. Previous NEC, meningitis, and septicemia were recorded if any of these were documented at the HCRN center either prior to the implantation of a temporizing device or prior to 32 weeks of gestation for those who did not undergo such a procedure. The NEC was further categorized as absent, medical NEC (no drain or resection required), or surgical NEC (required drain and/or bowel resection).
Neuroimaging Factors
These factors were abstracted by a pediatric neurosurgeon at each center. There was no set protocol at any center during the time of the study that determined if and when neuroimaging was obtained, other than as deemed clinically necessary. Baseline neuroimaging (CT scanning, MRI, or ultrasound imaging) was defined as the first cranial image available to the HCRN center that identified the Grade III or IV IVH. Clot size was recorded as the maximal length in millimeters of the intraventricular clot in any plane. Clots were described as hyperintense if they were brighter, isointense if equal, and hypointense if they were darker than surrounding white matter on CT or ultrasound imaging. The anatomical location within the ventricle with the maximal clot burden was chosen as the clot location. The FOR was used as a validated quantitative measure of ventricle size.
9,14 The pattern of ventriculomegaly was defined as either a triventricular pattern (only the lateral and third ventricles are enlarged) or a communicating pattern (lateral, third, and fourth ventricles are all enlarged). No baseline imaging could be found in 9 patients, and in 5 others the IVH had already dissipated; therefore, clot characteristics were missing for these patients.
To select images from comparable time points in treated and untreated patients, the pretemporization procedure or Week 32 imaging was defined as the last cranial imaging study prior to the temporizing device implantation, or the imaging study obtained closest to the infant's 32nd week of gestation for those in whom a temporizing device was not used. This time point was chosen because 32 weeks was both the mean and the median gestational age at which temporizing devices were inserted in the group that underwent surgery. Pretemporization procedure or Week 32 imaging was missing for 22 patients.
Preshunt conversion or Week 41 imaging was obtained only in those patients who underwent implantation of a temporizing device. It was defined as the last cranial imaging session prior to shunt insertion or the imaging study obtained closest to the infant's 41st week of gestation for those in whom a CSF shunt was not necessary. Again, this time point was chosen because 41 weeks was both the mean and the median gestational age at which implanted temporizing devices were converted to shunts. Preshunt conversion or Week 41 imaging was missing in 7 eligible patients.
Processes of Care Factors
Secondary outcomes examined included whether the infant's first NICU admission was at an HCRN center, and if not, the timing and reason (neurosurgical or other) for the transfer was recorded. Age at admission to the HCRN center's NICU and neurosurgery consultation were also examined. We also collected the total LOS, the number of admissions per patient, and the number and type of cranial imaging studies completed at the tertiary (HCRN-affiliated) center only.
Statistical Analysis
Comparisons among centers for each factor were conducted using chi-square analyses and the Fisher exact test for categorical variables and the Wilcoxon rank-sum test and the Kruskal-Wallis nonparametric test for continuous variables. The associated p values are reported.
For the entire cohort, the association of individual factors with the use of an implanted temporizing device was assessed using chi-square analyses and the Fisher exact test for categorical variables and the Wilcoxon rank-sum test and the Kruskal-Wallis nonparametric test for continuous variables. Similar comparisons were conducted to determine the association with conversion to a permanent CSF shunt.
Stepwise logistic regression was used to construct the multivariate model for factor association with the use of an implanted temporizing device. Tests for colinearity were performed among the significant risk factors identified using the univariate scheme. Only the variables with significance in univariate analyses (p < 0.05) were tested in multivariate logistic regression. Regression modeling is not reported for conversion to CSF shunt; the models examined were unstable because the number of infants with an implanted temporizing device who did not undergo CSF shunt placement was very low. All statistical analysis was conducted using SAS version 9.2 software.
Results
Baseline Clinical and Neuroimaging Characteristics
A total of 110 premature infants who met inclusion criteria across 4 HCRN centers were evaluated in this study. Their baseline clinical characteristics are shown in Table 1 . As expected, gestational age and birth weight covaried and demonstrated a small yet significant difference between individual centers, with a range of 1.5 weeks in gestational age. No differences were seen among the centers in terms of medical comorbidities. Overall, 16% of these infants had NEC (two-thirds of which was surgeryrelated), 3% had meningitis, and 18% had septicemia prior to any neurosurgical interventions. No deaths were recorded in this surgical sample.
Baseline neuroimaging data are shown in Table 2 . The mean FOR (ventricle size) of 0.59 qualitatively correlates to moderate-to-severe ventriculomegaly. 9 Twothirds of patients had a triventricular pattern of ventriculomegaly rather than a communicating pattern. Grade of IVH, clot characteristics, FOR, and the ventriculomegaly pattern differed significantly among HCRN centers.
Factors Associated With Use of an Implanted Temporizing Device
In the cohort, 73 (66%) of 110 patients underwent a temporization procedure, whereas the remaining 37 patients underwent placement of a permanent CSF shunt immediately, at a mean gestational age of 39.5 weeks. Implanted temporizing devices included either ventricular reservoirs ( (Table 3) . Radiological factors associated with use of a temporizing device included pretemporization procedure or Week 32 FOR (p = 0.003) and a communicating pattern of ventriculomegaly (p = 0.02), but not baseline FOR or the presence of residual intraventricular clot. In the test for colinearity of the significant risk factors identified, the only interaction found was between a bulging or full fontanel and splayed sutures. Of these 2 colinear factors, fontanel was selected as the candidate for multivariate regression modeling, because it is more widely used and thought to be more clinically reliable by the authors. In multivariate analysis, only HCRN center (p < 0.001), higher FOR (p = 0.04), and bradycardia episodes (p = 0.07) remained associated with the use of an implanted temporizing device. This model calibrated significantly (Hosmer-Lemeshow statistic p = 0.53) and was very accurate, with a c-statistic of 0.935.
Factors Associated With Conversion of an Implanted Temporizing Device to a Permanent CSF Shunt
A total of 102 (93%) of 110 neonates in this study ultimately underwent CSF shunt placement. Of the 73 children who underwent a temporization procedure, in 65 (89%) the initial treatments were converted to permanent CSF shunts. Clinical and neuroimaging factors univariately associated with conversion to a permanent shunt among those who underwent a temporization procedure included a bulging or full fontanel (p < 0.001) and higher preshunt conversion or Week 41 FOR (p = 0.002) ( Table 4) . Splayed sutures, OFC percentile change, the OFC prior to either surgery decision point, and HCRN center were not.
Processes of Care Among Centers
Only a minority of the cohort (10%, range 0%-20%) was first admitted to an HCRN center NICU, demonstrating the tertiary referral nature of our member centers for this condition (Table 5 ). More than three-quarters (78%) of transfers were for neurosurgical issues, and transfers only rarely (9%) occurred within these neonates' 1st week of birth. Patient transfer rates within 7 days of birth did not significantly differ among centers. There were differences, however, in center-specific mean ages at neurosur-gical consultation, ranging from 31 to 62 days of age (p = 0.009).
Many differences in processes of care for these patients were identified among centers. The mean number of admissions to the HCRN center per patient in the first 3 months of life varied significantly (p = 0.02), from 1.3 to 1.7 ( Fig. 1 left) . The median total LOS at the HCRN center per patient varied significantly (p < 0.001), from 15 to * Baseline neuroimaging could not be obtained for 9 patients, and in 5 others the clot had already dissipated (therefore denominator was 96 for all 4 HCRN centers, and as given for the individual institutions). † Baseline neuroimaging could not be obtained for 9 patients (therefore denominator was 101). ‡ Preoperative or 32-week imaging studies were missing in 22 patients (denominator was 88). Where more clarification was needed, the numerator and denominator are both given.
84 days (Fig. 1 right) . While in the HCRN center's NICU, patients underwent an average of 9 (range 0-28) cranial neuroimaging studies, including ultrasonography (mean 6.2/patient) and CT (mean 2.4/patient); however, the total number of cranial images per patient varied significantly among centers (p < 0.001) (Fig. 2) . This variation in imaging among centers was seen for ultrasound (p < 0.001) and CT only (p < 0.001); the rarer use of MRI was consistent among centers (mean 0.3/patient, not statistically significant).
Discussion
In this large multicenter cohort of 110 premature infants with Grade III or IV IVH who were surgically treated for hydrocephalus, we found that 73 patients (66%) were treated with temporization procedures at a mean age of 32 weeks, and in 37 (34%) CSF shunt placement was performed immediately. Factors independently associated with temporization procedures included center, larger ventricular size, and episodic bradycardia. In 89% of the infants, the temporizing device was converted to a permanent CSF shunt. A full or bulging fontanel and larger ventricular size were associated with this conversion. Significant variation in neurosurgical management for these neonates existed among HCRN centers.
Among the centers involved in this study, significant variation was seen between the treated populations, especially in terms of neuroimaging findings (Table 2) . We believe that the differences in clot size, density, location, and triventricular ventriculomegaly were, in part, related to interpretation issues, given that a separate pediatric neurosurgeon at each site abstracted these data points. Strict criteria were given a priori, but ultrasound imaging (which was used most) can vary significantly in quality and can be difficult to abstract. Future studies will require a centralized reading for exactly these issues. The FOR, as a measure of ventricular size, is very reliable between observers. 9 The FOR did differ significantly both at baseline and prior to temporization; however, prior to temporization, the FORs ranged only from 0.62 to 0.68, which is of minimal clinical significance. The age at admission to an HCRN center NICU did not account for the baseline difference in FOR. We suspect that the slightly more extreme prematurity at centers C and D contributed.
In addition to larger preoperative ventricular size and the presence of bradycardia episodes, the center where a neonate is treated is the strongest predictor of the decision to use a temporizing device. This "center effect" is probably due to a compilation of several highly variable factors within each center and provides a clinical confirmation of a recent finding from a questionnaire study among neonatologists. 5 The most probable factor accounting for center variation is neurosurgeon treatment thresholds, because no documented treatment algorithms or strategies for temporization existed during the years of this study at any of the centers. However, other hospital-specific factors such as admission patterns (that is, a single long-term tertiary NICU admission under the auspices of neurosurgery vs multiple short-term tertiary NICU admissions with transfers from the community hospital) in combination with varying neonatology philosophies of care may be contributing in a small way.
Degree of ventriculomegaly is more strongly associated with the use of a temporizing device than clinical signs such as apnea, split cranial suture, bulging fontanel, and OFC measurements (with the exception of bradycardia). This intriguing observation is consistent with previously published studies, 4, 13 which have suggested that the premature infant's brain is highly compliant to increasing intraventricular size, and it is not until later in the hydrocephalus process that the pressure begins to expand the cranial vault size, thereby increasing OFCs, splitting the sutures, and bulging the fontanel.
Whereas implantation of temporizing devices in this population is highly variable between centers, the conversion of these devices to permanent CSF shunts is not. Factors associated with permanent CSF shunt placement are bulging or full fontanel and larger ventricular size, which occurred despite temporization or during a trial of weaning of taps in the group with reservoirs. No specific tapping protocol was followed at any of the centers that used ventricular reservoirs during the timeline of the study. These risk factors are more consistent with traditionally held views within neurosurgical practice. 5 Thus, perhaps more consistency across centers is not unexpected. Again, it is interesting to note that apneas, bradycardias, splayed sutures, and OFCs were not predictive of the need for conversion to permanent CSF shunting.
An issue of concern at all centers is that these infants were referred to either a neurosurgery-associated NICU or the neurosurgery service in a delayed manner, with a mean of 44 days, especially considering that hemorrhages usually occur within the 1st week of birth. However, the degree of delay for neurosurgery consultation varied significantly (p = 0.009) between centers (range 31-62 days). Half of centers tend to admit the neonate and perform all treatment at that tertiary NICU, thereby having fewer admissions per patient and a longer LOS. The other centers focus the care at the referring NICU and transfer the in- fant more frequently but for short durations to the tertiary center for specific treatments only. Decentralized care poses logistical challenges both for standardizing treatment decisions and for prospective data collection when studying the care of these infants.
The clinical centers of the HCRN also differed significantly in the type of temporizing devices used (subcutaneous reservoir vs subgaleal shunt), patient chronological age at neurosurgical consult, and the frequency and modalities of neuroimaging used. We believe that these findings are representative of most tertiary care pediatric neurosurgery centers across North America. For any meaningful future study examining this population, these factors must be standardized for the results to maintain internal validity.
Limitations of the Study
The scope of this project was limited to the group of preterm infants with IVH who underwent neurosurgical intervention. The study was retrospective, and data collection was limited to what was recorded in the chart. Given the number of factors examined in analyses for the primary objective, our study had limited statistical power to demonstrate significance. This work was designed as a pilot in preparation for creating consensus surgical treatment algorithms for an upcoming prospective study. Therefore, we must temper our results and conclusions until they can be validated in the prospective study.
Conclusions
In this large multicenter cohort of 110 preterm infants with IVH who were surgically treated for hydrocephalus, 73 (66%) underwent temporization procedures. Aside from larger ventricular size and the presence of bradycardia, there was a significant "center effect" in determining whether patients underwent a temporization procedure. We believe, therefore, that standardized algorithms for this surgical decision point are necessary not only for future study but also for optimal patient care. Algorithms dictating this decision should weigh episodic bradycardia and ventricle size preferentially to other clinical findings of OFC increases or apnea episodes. They will need to standardize the timing of neurosurgical consultation and the frequency and modality of neuroimaging. Finally, attempts to standardize care will need to apply to care fragmented between referring and tertiary NICUs.
In 89% of the infants who underwent temporization procedures, the temporizing device was converted to a permanent CSF shunt. The decision to convert these temporizing devices into permanent CSF shunts was uniform across centers and was dominated by larger ventricle size and a bulging or full fontanel.
